(XENE) Xenon Pharmaceuticals - Performance -15.5% in 12m
XENE performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
42.06%
#12 in Peer-Group
Rel. Strength
24.49%
#5812 in Stock-Universe
Total Return 12m
-15.51%
#80 in Peer-Group
Total Return 5y
137.67%
#6 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 45.74 USD |
| 52 Week Low | 28.23 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 56.69 |
| Buy/Sell Signal +-5 | -1.45 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: XENE (-15.5%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: XENE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for XENE
| Total Return (including Dividends) | XENE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.10% | 0.53% | 3.75% |
| 3 Months | 11.30% | 21.37% | 25.32% |
| 12 Months | -15.51% | -9.11% | 13.11% |
| 5 Years | 137.67% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | XENE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 4.3% | -5.7% | 80.3% |
| 3 Months | -23.3% | 79.4% | 97.2% |
| 12 Months | -78.4% | -86.9% | 45.4% |
| 5 Years | 78.1% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.50 | -0.62% | -3.71% |
| 3 Month | %th35.50 | -8.30% | -11.19% |
| 12 Month | %th60.50 | -7.05% | -25.31% |
| 5 Years | %th97.50 | 221.14% | 13.29% |
FAQs
Does Xenon Pharmaceuticals (XENE) outperform the market?
No,
over the last 12 months XENE made -15.51%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months XENE made 11.30%, while XBI made 21.37%.
Performance Comparison XENE vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
XENE vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.5% | -3.9% | -26.4% | -29% |
| US NASDAQ 100 | QQQ | -3.1% | -4.3% | -28% | -27% |
| German DAX 40 | DAX | -4.4% | -0.3% | -39.2% | -46% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.6% | -3.9% | -30.2% | -37% |
| Hongkong Hang Seng | HSI | -2.1% | -3.2% | -46.9% | -54% |
| India NIFTY 50 | INDA | -1.8% | -0.9% | -27% | -15% |
| Brasil Bovespa | EWZ | -1.8% | -6% | -48.4% | -23% |
XENE vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.2% | -3.6% | -30.9% | -40% |
| Consumer Discretionary | XLY | -1.8% | -2.1% | -18.6% | -31% |
| Consumer Staples | XLP | -1.3% | -0.5% | -27% | -23% |
| Energy | XLE | -5.7% | -6.9% | -22.7% | -18% |
| Financial | XLF | -1.2% | -2.8% | -29% | -43% |
| Health Care | XLV | -0.8% | -1.2% | -17.5% | -11% |
| Industrial | XLI | -2.7% | -3.2% | -33.3% | -40% |
| Materials | XLB | -3.4% | -3.9% | -30% | -21% |
| Real Estate | XLRE | -1.4% | 0% | -25.3% | -27% |
| Technology | XLK | -4.2% | -7.3% | -30.5% | -26% |
| Utilities | XLU | -1.1% | -1.4% | -28.8% | -37% |
| Aerospace & Defense | XAR | -3.2% | -3.9% | -44.6% | -63% |
| Biotech | XBI | -4.1% | -0.6% | -12.3% | -6% |
| Homebuilder | XHB | -1.3% | -6.1% | -18.5% | -19% |
| Retail | XRT | -2.6% | -1.7% | -21.8% | -25% |
XENE vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -6.2% | -6.91% | -20.1% | -11% |
| Natural Gas | UNG | -0.2% | 10.4% | -7.2% | -9% |
| Gold | GLD | -1% | 0.7% | -44.3% | -55% |
| Silver | SLV | -3.8% | 0.2% | -42.1% | -34% |
| Copper | CPER | -9.1% | -10.2% | -46.9% | -34% |
XENE vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.3% | -1.2% | -22.7% | -12% |
| iShares High Yield Corp. Bond | HYG | -1.9% | -1.4% | -24.8% | -25% |